Lichtenberg, Frank R.
Lichtenberg, Frank R. 1951-
Lichtenberg, Frank R., 19..-....
Frank R. Lichtenberg
VIAF ID: 212442788 ( Personal )
Permalink: http://viaf.org/viaf/212442788
Preferred Forms
- 100 0 _ ‡a Frank R. Lichtenberg
- 200 _ | ‡a Lichtenberg ‡b Frank R.
-
-
-
-
-
-
-
- 100 1 _ ‡a Lichtenberg, Frank R.
-
- 100 1 _ ‡a Lichtenberg, Frank R.
-
- 100 1 _ ‡a Lichtenberg, Frank R. ‡d 1951-
- 100 1 _ ‡a Lichtenberg, Frank R. ‡d 1951-
- 100 1 _ ‡a Lichtenberg, Frank R. ‡d 1951-
- 100 1 _ ‡a Lichtenberg, Frank R., ‡d 19..-....
4xx's: Alternate Name Forms (9)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
allocation of publicly funded biomedical research | |
Are increasing 5-year survival rates evidence of success against cancer? a reexamination using data from the U.S. and Australia | |
The benefits and costs of newer drugs : evidence from the 1996 Medical Expenditure Panel Survey | |
The comparative advantage of educated workers ... 1985 | |
Computer use and productivity growth ... c1996: | |
contribution of pharmaceutical innovation to longevity growth in Germany and France | |
Corporate takeovers and productivity | |
Diagnostic and therapeutic odyssey : essays in health economics | |
Does misery love company? : evidence from pharmaceutical markets before and after the orphan drug act | |
The dual effects of intellectual property regulations: within- and between- patent competition in the US pharmaceuticals industry | |
The effect of changes in drug utilization on labor supply and per capita output | |
The effect of drug vintage on survival micro evidence from Puerto Rico's Medicaid program | |
The effect of education on medical technology adoption : are the more educated more likely to use new drugs? | |
The effect of new drugs on mortality from rare diseases and HIV | |
The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans : Evidence from the 2004 National Nursing Home Survey | |
The effect of takeovers on the employment and wages of central-office and other personnel | |
The effects of mergers on prices, costs, and capacity utilization in the U.S. air transportation industry, 1970-84 | |
effects of off-label drug use on disability and medical expenditure | |
Errance diagnostique et thérapeutique : essais en économie de la santé. | |
The expanding pharmaceutical arsenal in the war on cancer | |
Has medical innovation reduced cancer mortality? | |
The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate U.S. time-series data | |
The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001 | |
impact of recent chemotherapy innovation on the longevity of myeloma patients U.S. and internationnal evidence | |
Importation and innovation | |
International R&D spillovers : a re-examination | |
Izazovi menadžmenta u XXI. stoljeću | |
The output contributions of computer equipment and personnel : a firm-level analysis | |
Pharmaceutical embodied technical progress, longevity, and quality of life: drugs as "equipment for your health" | |
The quality of medical care, behavioral risk factors, and longevity growth | |
R&D collaboration and specialization in the European Community | |
Response to Baker and Fugh-Bermanś critique of my paper, "Why has longevity increased more in some states than in others?" | |
Science war and peace | |
Sources of U.S. longevity increase, 1960-1997 | |
Technological change, trade, and the need for educated employees implications for economic policy |